Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.4000
-0.0520 (-11.50%)
At close: May 15, 2025, 4:00 PM
0.4120
+0.0120 (3.00%)
After-hours: May 15, 2025, 7:59 PM EDT
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $11.62 million as of May 15, 2025. Its market cap has decreased by -50.35% in one year.
Market Cap
11.62M
Enterprise Value
9.18M
1-Year Change
-50.35%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $11.62M, a decrease of -95.36%. That is a compound annual growth rate of -24.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 13.10M | -2.24% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | -57.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 644.57B |
| Johnson & Johnson | 358.36B |
| AbbVie | 314.81B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 236.76B |
| Abbott Laboratories | 230.39B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |